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In a rabbit model we investigated the efficacy of a silk fibroin/hydroxyapatite (SF/HA) 
composite on the repair of a segmental bone defect. Four types of porous SF/HA 
composites (SF/HA-1, SF/HA-2, SF/HA-3, SF/HA-4) with different material ratios, pore sizes, 
porosity and additives were implanted subcutaneously into Sprague-Dawley rats to observe 
biodegradation. SF/HA-3, which had characteristics more suitable for a bone substitite 
based on strength and resorption was selected as a scaffold and co-cultured with rabbit 
bone-marrow stromal cells (BMSCs). A segmental bone defect was created in the rabbit 
radius. The animals were randomised into group 1 (SF/HA-3 combined with BMSCs 
implanted into the bone defect), group 2 (SF/HA implanted alone) and group 3 (nothing 
implanted). They were killed at four, eight and 12 weeks for visual, radiological and 
histological study.
The bone defects had complete union for group 1 and partial union in group 2, 12 weeks 
after operation. There was no formation of new bone in group 3. We conclude that SF/HA-3 
combined with BMSCs supports bone healing and offers potential as a bone-graft 
substitute.
Although bone has the capacity for regenerative
growth and remodelling, these processes are
often impaired in clinical situations in which
loss of bone is caused by disease, trauma or
tumour resection. It has been estimated that
more than 800 000 bone grafts are performed
annually worldwide.1 Large bone defects repre-
sent a major problem in reconstructive surgery.
Currently promotion of bone healing depends
on autogenous and allogenic bone grafts, het-
erogeneous bone and synthetic materials.2-4
Autologous bone grafting is the standard
against which the repair of bone defects is
judged. It provides the three elements neces-
sary to generate and maintain bone, namely, an
osteoconductive scaffold for bone ingrowth,
osteoinductive growth factors and osteogenic
progenitor cells. However, there are some dis-
advantages in this approach, including the
extra incision required to obtain the graft, an
increased operating time, the morbidity of the
bone-graft incision donor site and infection.5-7
Additionally, the amount of bone harvested
may be insufficient. Allografts are generally
available from tissue banks, but have the risk
of transmission of disease and post-operative
complications because of failure of vasculari-
sation.8,9 New approaches include the use of
conductive and inductive biomaterials contain-
ing bioactive molecules to promote cell migra-
tion and cell transplantation to the defect site
in order to repair bone defects.10-13
The ideal scaffold should provide a suitable
environment for tissue development. It should
have good biocompatibility without any detri-
mental effects on surrounding tissues and
favour the attachment of seeded cells and their
growth and subsequent differentiation. It
should also favour revascularisation, be osteo-
conductive, inductive, and osteointegrate with
the host bone, have the potential to biodegrade
while being gradually replaced by the newly-
formed bone, be adaptable to an irregularly-
shaped defect and support mechanical loading;
and be storable and able to be sterilised with-
out loss of properties.14-16
However, a single material rarely has all of
these prerequisites. The development of com-
posite materials may offer a way forward. Silk
fibroin extracted from a silkworm cocoon is an
ideal biomaterial for medical application17,18
with studies showing that its toughness is bet-
ter than that of collagen and that it can be used
to reinforce inorganic materials.19 We believe
that silk fibroin/hydroxyapatite (SF/HA) as an
artificial bone substitute may be applicable as a
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scaffold. We have therefore investigated the reconstruction
of segmental bone defects in a rabbit model using an SF/HA
composite combined with rabbit bone-marrow stromal
cells (BMSCs) as implants for bone healing.
Materials and Methods
Degradation of SF/HA in vivo. With conventional HA as a
control group, four types of SF/HA (SF/HA-1, SF/HA-2, SF/
HA-3 and SF/HA-4) were made into cubes (5 mm × 5 mm
× 5 mm). Six samples of each were used. The composition
of the types of SF/HA and their characteristics are given in
Tables I and II. Sodium chloride was used as a porogen and
short fibres were used to improve the resilience of the SF/
HA. Starch was used to speed up the degradation of SF/HA.
These materials, after sterilisation by irradiation from a
cobalt60 source were implanted subcutaneously into the
lumbar region of Sprague-Dawley rats so that their degra-
dation and tissue reaction could be observed. The degrada-
tion was analysed macroscopically and histologically at
two, six, 12, 16, 20 and 24 weeks after operation.
Isolation and expansion of rabbit BMSCs. Using two-month-
old New Zealand white rabbits BMSCs were isolated by den-
sity-gradient centrifugation from harvests of whole bone of
approximately 5 ml obtained from the femoral condyle and
tibial plateau. The adherent cells were allowed to reach
approximately 80% confluence at about 14 days at passage
0. The cells were trypsinised and re-plated at a density of
5000 cells per cm2 on 500 cm2 triple flasks and cultured
between seven and ten days or until they reached about 90%
confluence. After trypsinisation, these cells were used to seed
the scaffolds as described below.
Scaffold selection and tissue culture. Based on the result of
the degradation of SF/HA in vivo, SF/HA-3 was selected for
the scaffold. For cultivation on the scaffold of SF/HA-3,
which was 15 mm × 3 mm × 3 mm in size rabbit BMSCs of
90% confluence were suspended in liquid Dulbecco’s mod-
ified Eagle’s medium (DMEM; 5 × 107 cells per ml) and the
suspension was seeded on to a pre-wetted scaffold
(overnight incubation of scaffold in DMEM). The ordinary
cell culture medium was prepared as follows: DMEM sup-
plemented with 10% fetal bovine serum (FBS), 100 μ/ml of
penicillin and Fungizone, 5.8 g/l of hydroxyethyl piperazine
ethanesulfonic acid, 2 g/l of NaHCO3 and 0.3 g/l of glu-
tamine, with the pH adjusted from 7.2 to 7.4. The osteo-
genic medium was prepared as follows: the ordinary cell
culture medium was supplemented with 50 gμ/ml of ascor-
bic acid-2-phosphate, 1 × 10-8 g/l of dexamethasone and 10
mmol/l of β−glycerophosphate, Ascorbic acid-2-phosphate,
dexamethasone and β−glycerophosphate were used as
osteogenic inducing agents. The flasks were placed in a
humidified incubator at 37°C and 5% CO2 with the side-
arm caps loosened to allow gas exchange. Half of the osteo-
genic medium was replaced every three days.
Rabbit radial segmental bone defects. For the in vivo experi-
ments we used 54 three-month-old New Zealand white rab-
bits, weighing between 2.0 kg and 2.5 kg. All the procedures
were performed under a protocol approved by Soochow
University Orthopaedics Centre Laboratory in accordance
with the Guide for Care and Use of Laboratory Animals.20
The rabbits were anaesthetised with an intramuscular injec-
tion of ketamine (1 ml/kg) into the buttocks and given lido-
caine as a local anaesthesia. They maintained spontaneous
breathing throughout. After they were shaved and the skin
prepared in a standard fashion with antiseptic solution, one
front leg of each rabbit was draped. A vertical skin incision
4 cm long was made over the middle of the anteromedial
aspect of the radius and a 20 mm section of the radius with
its periosteum was removed through an osteotomy. The scaf-
fold was implanted into the defect which had been created
without any gap between the material and the host bone.
The diameter of the scaffold almost matched the diameter of
the radius. The rabbits were randomly divided into three
experimental groups. Group 1 was implanted with the tis-
sue-engineered bone, group 2 with scaffold (SF/HA-3) alone
and group 3 had no implants and were left with the defect
unfilled.
After the implantation of materials, the incision was
closed with a 1-0 fiber thread suture line in a routine fash-
Table I. The composition ratio of silk fibroin/hydroxyapatite (SF/HA)
HA (g) SF (g) Short fibre (g) NaCI (g) Starch (g)
SF/HA-1 u 5u 0 2u 0
SF/HA-2 u 4u 2%u 2u 0
SF/HA-3 u 2u 2%u 3u 50%u
SF/HA-4 u 3u 2%u 3u 50%u
Table II. The characteristics of the four types of silk fibroin/hydroxyapatite (SF/HA)
SF/HA-1 SF/HA-2 SF/HA-3 SF/HA-4
Porosity (%) 65.0   66.0   80.0   95.0
Apparent density (g/cm3)  0.76   0.77     0.74    0.44
Mean pore size (μm)   6.5 (3 to 15)   68.9 (24 to 143.6) 120.0 (30 to 345) 253.0 (139 to 531)
Mean compressive strength (MPa) 15.24 (12.28 to 19.31) 16.44 (13.87 to 21.42)   10.1 (8.67 to 11.64)     1.59 (0.98 to 1.87)
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ion. The rabbits were allowed to recover from the anaesthe-
sia without restrictions.
From each group six rabbits were killed at four, eight and
12 weeks after operation by injection of air under pento-
barbital anaesthesia. Radiographs were obtained, a visual
assessment was undertaken and histological examination
was performed.
Radiological evaluation. Anteroposterior (AP) and lateral
views of the operated radius were checked every four weeks
to compare the serial changes of callus in the bone-defect
site and the time of formation of cortical bone and the med-
ullary cavity. The formation of new bone in the defect was
evaluated radiologically at four, eight, and 12 weeks after
operation according to the Lane-Sandhu radiological
score.21 The score operates from three aspects. 1. The
degree of bone formation (as an area of the total defects).
2. The degree of new bone connecting with host bone. 3.
The amount of bone remodelling (with or without bone
marrow cavity formation or cortical bone formation).
Visual assessment. Healing of the defect was evaluated visu-
ally in all groups at four, eight and 12 weeks after operation.
Histological assessment. A biopsy was obtained from the
region of the excised radius and the adjacent normal bone
from each rabbit. The resected radius was placed in 40%
ethyl alcohol for two days. The samples were subsequently
dehydrated by passing through increasing strengths of ethyl
alcohol and were processed to produce undecalcified,
plastic-embedded ground sections. The sections were then
stained with haematoxylin and eosin and examined under
light microscopy for characterisation of new bone and
residual implant material in the defects. The formation of
new bone in the defect was evaluated histologically at four,
eight and 12 weeks after operation according to the Lane-
Sandhu histological score.21
Bone strength test. From group 1 in which, on visual
assessment, bone defects had repaired completely at
12 weeks, four radii were selected for the testing of bone
strength. The contralateral normal radii were used as a
control group. Bone strength was measured by a three-
point bending test. A 5 cm length of the bone segment
including the area which had been replaced with the bone
substitute was harvested. The test was undertaken using a
Materials testing machine (MTS 858 Mini Bionix II; MTS,
Albany, New York). Two supporting jigs were set on the
instrument and the harvested bone segment was posi-
tioned. Each jig was placed 10 mm from the resected mar-
gin. The three-point bending test was performed with a
cross-head speed of 1 mm/min with a 100 kg load cell.
Statistical analysis. The radiological score, histological
score and biomechanical data were statistically analysed
by SAS version 8.0 software (SAS Institute Inc., Cary,
North Carolina). The results are presented as the mean
and SD. The radiological score of each group was
compared using analysis of variance (ANOVA). The histo-
logical scores of group 1 and group 2 were compared
using Student’s t-test. The values of the bone-strength tests
of the radius were compared with those of the contralat-
eral normal radius using a paired sample t-test. A p-value
of ≤ 0.05 was considered to be statistically significant.
Results
Degradation of SF/HA in vivo. HA, SF/HA-1 and SF/HA-2
showed little degradation within 24 weeks of the opera-
tion whereas SF/HA-3 had complete degradation in 12 to
16 weeks and SF/HA-4 within 12 weeks. Histological
examination of tissue surrounding all four groups showed
no evidence of apomorphosis and necrosis. There was no
tissue growth in SF/HA-1 and SF/HA-2 while fibrous tis-
sue and vascular tissue growth were identified in SF/HA-3
and SF/HA-4.
SF/HA-1 and SF/HA-2 were therefore considered to be
unsuitable as a bone-tissue engineering scaffold because
they were not degradable. SF/HA-4 was also considered to
be unsuitable because its mean ability to resist pressure
was 1.59 MPa (0.98 MPa to 1.87 MPa), which was insuf-
ficient for a scaffold. Therefore SF/HA-3 was selected as
the scaffold.
Rabbit radial segmental bone defects
Radiological. In group 1, abundant callus was observed in
the entire bone-defect site, which was connected to the
bone fragment on both sides of the bone defect at four
weeks. Cortical bone and the establishment of a medullary
canal had partly appeared at eight weeks. Bone consolida-
tion and formation of a medullary canal were clearly visible
at 12 weeks (Fig. 1).
In group 2, a small amount of callus had formed at the
edges of the bone-defect site at four weeks. Comparatively,
more callus had formed on both edges of the bone defect at
eight weeks. The callus did not connect the bone fragments
on both sides to the scaffold (SF/HA-3) which had nearly
completely degraded at 12 weeks. The bone defect was
partly repaired (Fig. 2). In group 3, very little callus formed
at the edge of the bone-defect site from four to 12 weeks
(Fig. 3).
There were significant differences in the radiological
scores at four, eight and 12 weeks after operation in groups
1, 2 and 3 (Table III). Bone formation was best in group 1
followed by group 2 and then group 3.
Fig. 1 
Group 1. Radiograph showing bony consolidation and restoration of the
medullary canal at 12 weeks.
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Visual assessment. Ingroup 1, fibrocartilage was seen in
the whole bone defect and had enveloped the tissue-
engineered bone at four weeks. Callus had formed at eight
weeks. By 12 weeks, new bone remodelling was continuous
and was the same as normal bone at 12 weeks (Fig. 4).
In group 2, some fibrocartilage was seen at the edges of
the bone defect at four weeks. Some callus had formed at
the edges at eight weeks and the material had partly
degraded. At 12 weeks, formation of new bone had
occurred at the edges, but the bone defect had not repaired
by the time the scaffold degraded (Fig. 5). In group 3,
there was no formation of new bone between four and
12 weeks (Fig. 6).
Histological. In group 1, abundant new cartilage and
some woven bone were seen around the residual materi-
als at four weeks. At eight weeks, more woven bone had
formed, and ossification was identified. At 12 weeks cor-
tical continuity and formation of the medullary cavity
were seen in some parts of the woven bone.
In group 2, cartilage cells and some osteoblasts
started to appear at the edge of the bone defect in the
presence of residual material at four weeks. At eight
weeks, some woven bone trabeculae were seen partly at
the margin. At 12 weeks, more formation of new bone
was seen at the edge of the defect, but with little residual
scaffold material remaining. In group 3, histological
examination was not carried out since there was no for-
mation of new bone.
There were significant differences at four, eight and
12 weeks after operation in the histological scores of group
1 and group 2 (Table IV). The results showed that the for-
mation of bone in group 1 was better than that in group 2.
Bone strength test. The mean results of the three-point test
were 96.25 N (SD 4.84) in group 1 and 102.23 N (SD 9.33)
Fig. 2
Group 2. Radiograph showing that the callus did not connect the bone
fragments on both sides of the bone defect and that the scaffold (SF/HA-
3) had degraded completely at 12 weeks.
Fig. 3
Group 3. Radiograph showing that no callus had formed at the margins
of the site of the bone defect at 12 weeks.
Table III. The mean (SD) Lane-Sandhu21 radiological score at four, eight and 12 weeks in
groups 1, 2 and 3
Group
Time (wks) 1 2 3 p-value (ANOVA)
4   3.5  (0.55) 2.00  (1.10) 0.67  (0.52) 0. 0003
8   7.17 (1.17) 3.83  (0.98) 0.83  (0.41) < 0.001
12 10.67 (1.51) 5.33  (0.52) 1.17  (0.41) < 0.001
Fig. 4
Group 1. Photograph showing new cortical bone forming and remodel-
ling. It was difficult to discriminate from normal bone at 12 weeks.
Fig. 5
Group 2. Photograph showing new bone formation at the edges of bone
defect at 12 weeks. However, the defect remained incompletely repaired
and the scaffold had degraded.
324 G. WANG, H. YANG, M. LI, S. LU, X. CHEN, X. CAI
THE JOURNAL OF BONE AND JOINT SURGERY
in the control group. There was no statistical significance
between them (t-test, p = 0.287).
Discussion
Hydroxyapatite is the major inorganic phase of bone to
which host bone will form a direct bond.22 However, it is
not a perfect scaffold material for bone substitution
because of its poor mechanical properties and minimal deg-
radation in vivo.23 Silk fibroin extracted from the cocoon is
an ideal biomaterial for medical applications. It is non-toxic
and non-polluting with good tissue compatibility and bio-
degradability.24 The amino-acid composition of silk fibroin
is similar to that of the keratin of skin and hair, with excel-
lent physiochemical properties and good biocompatibility.17
Silk fibroin can support the adhesion and proliferation of
cells as can other biomaterials which are modified by silk
fibroin.18,25 Additionally, the inflammatory response
induced by silk fibroin is less marked compared with that of
collagen although the ability to support cell adhesion, pro-
liferation, differentiation and growth is the same.26 Studies
have shown that the toughness of silk fibroin is better than
that of collagen and it can be used to reinforce inorganic
materials.19 In addition, compared with the commercially
produced type-I collagen, silk fibroin is easy to extract, less
expensive and is thus a promising tissue-engineering mate-
rial. Bone scaffold needs a certain strength to maintain its
shape during the formation of bone. However, the strength
of silk fibroin is not sufficient for use as a bone scaffold
alone. Thus, we incorporated hydroxyapatite in silk fibroin
to improve its strength preparing an SF/HA porous com-
posite material by isostatic pressing technology.
The degradation experiment showed that the four types
of SF/HA which we produced had significantly different
rates of degradation which seemed to depend on the size of
the pore, porosity, the presence of starch and the propor-
tions of HA and SF in the material. The degradation rate of
SF/HA-1 and SF/HA-2 is similar to that of pure HA with
almost no degradation within six months. The degrada-
tion rate of SF/HA-3 and SF/HA-4 was faster than that of
SF/HA-1 and SF/HA-2 as a result of the porosity as well as
the content of silk fibroin and the addition of starch. Pre-
vious studies have shown that pore size and porosity have
significant effects on the degradation property of materials.
The greater the porosity is the faster the dissolution.27 The
pore increases the contact area between the material and
tissue fluid, which faciliates biodegradation as well as the
formation of new bone.28,29 Our study did not explore the
biodegradation mechanism.
The ideal bone-graft substitute should be replaced com-
pletely by new bone. In bone-tissue engineering, the co-
ordination between the biodegradation of material and the
formation of bone is very important. Previous studies have
shown that if the rate of degradation is too fast, the mate-
rial will collapse, and compromise the repair, but if the rate
is too slow, the formation of new bone, remodelling and
reconstruction will be hindered.30 The bone-graft substitute
should be resorbed at a rate which balances the growth of
new bone.31 Ceramic substitutes such as hydroxyapatite
may inhibit bone formation and weaken the intensity of
newly-formed bone because they typically persist for longer
than is required for the formation of new bone. SF/HA-3
degraded at a compatible rate and this was complete within
12 to 16 weeks, providing a scaffold for bone formation
without hindering bone remodelling. With regard to bio-
degradation, both SF/HA-3 and SF/HA-4 are suitable bio-
scaffold materials, but SF/HA-4 is not able to maintain its
shape because of its poor mechanical properties.
SF/HA-3 has an excellent three-dimensional porous
structure, a high specific surface area and sufficient strength
which created the conditions for the formation of new
bone. Generally, a pore size of less than 100 μm can support
the ingrowth of connective tissue, but is not favourable for
osteocytic ingrowth.32 Jones, Ahir and Hench33 reported
that satisfactory results were achieved by applying bio-
active glass with a pore size greater than 100 μm as a tissue-
engineering scaffold. The mean pore size of SF/HA-3 was
120 μm (the greatest size is 345 μm) and the porosity was
80% which met the requirement for a bone-substitute mate-
rial. The latter is another basic requirement of scaffold mate-
rials. It has been shown that new tissue can advance from the
surface of a porous material into the inner part if the porosity
is greater than 50% and the pores are interconnected.34 The
increase in porosity can improve the specific surface area
and facilitate cell ingrowth, but decreases the mechanical
strength of the material. The ideal bone-tissue engineering
scaffold should have an appropriate porosity while still
maintaining a certain shape. In our experiment, the mean
mechanical strength of SF/HA-3 was 10.1 MPa when the
porosity was up to 80%, which ensured the maintenance of
Fig. 6
Group 3. Photograph showing no new bone formation at the site of the
bone defect at 12 weeks.
Table IV. The mean (SD) Lane-Sandhu21 histological score at
four, eight and 12 weeks in groups 1 and 2
Group
Time (wks) 1 2 p-value (ANOVA)
4   3.50  (0.84) 2.50  (0.55) 0.0343
8   7.83 (0.76) 4.67  (0.81) < 0.0001
12 10.50 (1.05) 6.17  (1.17) < 0.0001
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the scaffold shape during bone formation and met the basic
strength requirement of bone-tissue scaffold material.
Therefore SF/HA-3 was chosen as the scaffold material.
Our study showed that the tissue-engineered bone based
on SF/HA-3 had a good proliferative effect with healing of
a segmental bone defect of 20 mm within 12 weeks. It sug-
gested that BMSCs continued to proliferate and differenti-
ate in the scaffold after implantation without immune
rejection, showing that SF/HA-2 had good cytocompatibil-
ity. The three-point bending test indicated that the strength
of the regenerated zone was similar to that of normal bone.
In group 2, some repair of the defect did occur com-
pared with group 3, but was incomplete. This suggested
that SF/HA alone had no bone-inductive property, but did
have some capacity for bone conduction. There was no
obvious change except for the presence of fibrous tissue in
the bone-defect zone in group 3, which suggested that the
defect could not heal by itself. 
In summary, the degradation rate and porosity of SF/HA
varies with the content of silk fibroin, hydroxyapatite,
additives and porogen. SF/HA-based tissue-engineered
bone with a sufficient rate of degradation, pore size and
porosity with added bone-marrow stromal cells could
strike a balance between the formation of new bone and
material absorption and form functional bone tissue within
a short period, meeting the basic requisites of modern bone-
tissue engineering science. However, the SF/HA scaffold
alone has no bone-inductive effect and the ability to repair
a segmental bone defect by the application of SF/HA in
isolation is limited.
No benefits in any form have been received or will be received from a commer-
cial party related directly or indirectly to the subject of this article.
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